Driving the Future of Vaccine Innovation at Ghent University Hospital
Ready to collaborate on developing, testing, and producing new vaccines and therapeutics? Let’s advance together.
Vaxadvance brings together world-class expertise in vaccine research, clinical trials, and advanced manufacturing.
We unite four leading entities— Center for Vaccinology (CEVAC), the GMP Unit UZ Gent, and the NanoMedicine Centre (NMC), Core ARTH Animal Facilities —to provide a comprehensive services for developing and producing next-generation vaccines, including mRNA and saRNA platforms.
Our goal is to accelerate breakthroughs in vaccine and therapeutic development from the lab bench to real-world clinical applications.
GMP Unit UZ Gent
CellGEN Therapies
Advanced Therapies and Clinical-Grade Production at CellGEN Therapies
Core ARTH Animal Facilities
Animal Facilities
Advancing preclinical, biomedical and laboratory animal research
